References
-
1) Silencing of RSPO1 mitigates obesity-related renal fibrosis in mice by deactivating Wnt/β-catenin pathway.
Product: GSK3 beta Antibody (#AF5016)Year: 2021Journal: EXP CELL RESImpactFactor: 3.3DOI: 10.1016/j.yexcr.2021.112713PMID: 34181940 -
2) Platelet-rich plasma protects human melanocytes from oxidative stress and ameliorates melanogenesis induced by UVB irradiation.
Product: GSK3 beta Antibody (#AF5016)Year: 2021Journal: Biosci Biotechnol BiochemImpactFactor: 1.4DOI: 10.1093/bbb/zbab085PMID: 33974003 -
3) Histone deacetylase inhibitor induced pVHL-independent degradation of HIF-1α and hierarchical quality control of pVHL via chaperone system.
Product: GSK3 beta Antibody (#AF5016)Year: 2021Journal: PLOS ONEImpactFactor: 2.9DOI: 10.1371/journal.pone.0248019PMID: 34329303 -
4) TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis.
Product: GSK3 beta Antibody (#AF5016)Year: 2021Journal: TRANSL LUNG CANCER RImpactFactor: 4DOI: 10.21037/tlcr-21-147PMID: 33718034 -
5) S100A2 Silencing Relieves Epithelial–Mesenchymal Transition in Pulmonary Fibrosis by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Product: GSK3 beta Antibody (#AF5016)Year: 2021Journal: DNA CELL BIOLImpactFactor: 2.6DOI: 10.1089/dna.2020.6030PMID: 33306933 -
6) TSG101 Promotes the Proliferation, Migration, and Invasion of Human Glioma Cells by Regulating the AKT/GSK3β/β-Catenin and RhoC/Cofilin Pathways.
Product: GSK3 beta Antibody (#AF5016)Year: 2021Journal: MOL NEUROBIOLImpactFactor: 4.6DOI: 10.1007/s12035-020-02231-7PMID: 33411238 -
7) The miR‑136‑5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells.
Product: GSK3 beta Antibody (#AF5016)Year: 2021Journal: EXP THER MEDImpactFactor: 2.4DOI: 10.3892/etm.2021.9748PMID: 33717260 -
8) A network-based analysis of key pharmacological pathways of Andrographis paniculata acting on Alzheimer's disease and experimental validation.
Product: GSK3 beta Antibody (#AF5016)Year: 2020Journal: J ETHNOPHARMACOLImpactFactor: 4.8DOI: 10.1016/j.jep.2019.112488PMID: 31866509 -
9) Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Product: GSK3 beta Antibody (#AF5016)Year: 2020Journal: PHARMACOLOGYImpactFactor: 2.9DOI: 10.1159/000506081PMID: 32062649 -
10) Downregulation of S100A2 alleviates pulmonary fibrosis through inhibiting wnt/β-catenin signaling pathway.
Product: GSK3 beta Antibody (#AF5016)Year: 2020Journal: Research SquareDOI: 10.21203/rs.3.rs-23375/v1 -
11) Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage.
Product: GSK3 beta Antibody (#AF5016)Year: 2019Journal: J BIOL CHEMImpactFactor: 4DOI: 10.1016/j.biopha.2019.109503PMID: 31590127 -
12) Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway.
Product: GSK3 beta Antibody (#AF5016)Year: 2018Journal: MAR DRUGSImpactFactor: 5.4DOI: 10.3390/md16030082PMID: 29509717 -
13) α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway.
Product: GSK3 beta Antibody (#AF5016)Year: 2017Journal: ONCOGENESISImpactFactor: 5.9DOI: 10.1038/oncsis.2017.40PMID: 28553930 -
14) MicroRNA-200c impairs uterine receptivity formation by targeting FUT4 and α1,3-fucosylation.
Product: GSK3 beta Antibody (#AF5016)Year: 2017Journal: CELL DEATH DIFFERImpactFactor: 13.7DOI: 10.1038/cdd.2017.136PMID: 28914881 -
15) Hepatic IGF-1R overexpression combined with the activation of GSK-3β and FOXO3a in the development of liver cirrhosis.
Product: GSK3 beta Antibody (#AF5016)Year: 2016Journal: LIFE SCIImpactFactor: 5.2DOI: 10.1016/j.lfs.2016.01.037PMID: 26826001